Case number 1:24-cv-00753
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Granules India Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 16, 2024 | 10 | CONSENT JUDGMENT in favor of Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. against Granules India Limited. Signed by Judge Colm F. Connolly on 10/16/2024. (kmd) (Entered: 10/16/2024) (4) |
| Oct 7, 2024 | 9 | PROPOSED CONSENT JUDGMENT by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 10/07/2024) (4) |
| Aug 14, 2024 | 8 | WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH: For Granules India Limited waiver sent on 8/13/2024, answer due 10/15/2024. (Dellinger, Megan) (Entered: 08/14/2024) (1) |
| Jul 3, 2024 | N/A | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) (Entered: 07/03/2024) (0) |
| Jul 3, 2024 | 7 | STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) (Entered: 07/03/2024) (2) |
| Jun 25, 2024 | 1 | COMPLAINT FOR ANDA/PATENT INFRINGEMENT filed against Granules India Limited (Filing fee $ 405, receipt number ADEDC-4437999.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # 1 Exhibit 1-2, # 2 Civil Cover Sheet)(jfm) (Entered: 06/26/2024) (0) |
| Jun 25, 2024 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 06/26/2024) (3) |
| Jun 25, 2024 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than May 13, 2024. Date of Expiration of Patent: August 5, 2029.Thirty Month Stay Deadline: 11/13/2026. (jfm) (Entered: 06/26/2024) (1) |
| Jun 25, 2024 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,486,526 B2; 10,034,877 B2. (jfm) (Entered: 06/26/2024) (1) |
| Jun 25, 2024 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG. for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. (jfm) (Entered: 06/26/2024) (2) |
| Jun 25, 2024 | 6 | Summons Issued as to Granules India Limited on 6/25/2024. (jfm) (Entered: 06/26/2024) (2) |
